VYTRUS BIOTECH EO -01 (V5P) — Working Capital to Net Assets Ratio

VYTRUS BIOTECH EO -01 (V5P) has a Working Capital to Net Assets ratio of 35.0% as of December 2025. Working capital of €3.61 Million (current assets of €5.39 Million minus current liabilities of €1.78 Million) is measured against net assets of €10.31 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See VYTRUS BIOTECH EO -01 defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.